Related Experiment Video

Updated: Aug 5, 2026

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways

X Gao1, T P Neufeld, D Pan

  • 1Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas, 75235-9040, USA.

Developmental Biology
|May 3, 2000
PubMed

Insights

Drosophila dPTEN, a tumor suppressor, controls cell and organ growth. Loss of dPTEN boosts cell proliferation and size, impacting organism development and potentially explaining PTEN mutations in human cancer.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Genetics

Background:

  • Cell and organ growth control is crucial for multicellular organisms.
  • PTEN (Phosphatase and tensin homolog) is a known tumor suppressor gene in mammals.

Purpose of the Study:

  • To investigate the role of Drosophila dPTEN, a homolog of mammalian PTEN, in regulating cell and organ size.
  • To elucidate the signaling pathways involved in dPTEN-mediated growth control.

Main Methods:

  • Utilizing mosaic animals to observe the effects of dPTEN loss-of-function and overexpression.
  • Genetic analysis involving mutations in PI3K (Phosphatidylinositol 3-kinase) pathway components like Dakt1 and translational factors like eif4A.

Main Results:

  • Loss of dPTEN leads to increased cell proliferation, cell size, and organ size in Drosophila.
  • Overexpression of dPTEN results in opposite phenotypes.
  • dPTEN's function is linked to the PI3K signaling pathway, regulating translation.
  • dPTEN influences both cell proliferation and growth, potentially through both PI3K/Akt-dependent and -independent pathways.
  • dPTEN does not significantly impact cell survival during development.

Conclusions:

  • Drosophila dPTEN is essential for controlling cell, cell number, and organ size.
  • dPTEN functions via the PI3K signaling pathway to regulate translation and overall growth.
  • These findings offer insights into the role of PTEN mutations in human cancers.

More Related Videos

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics10:31

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics

Published on: October 6, 2016

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...